Alexx Ekubo: ‘Very Common in Men’ 12 Things To Know About Metastatic Kidney Cancer
Family Confirms Death of Actor Alexx Ekubo Due to Kidney Cancer Complications
The family of actor Alexx Ekubo announced his passing on Wednesday via his official Instagram account, revealing he succumbed to complications from advanced metastatic kidney cancer. The actor died at Evercare Hospital after a brief medical battle.
In their statement, the family expressed profound sadness over the loss of their beloved husband, son, brother, and friend. They emphasized Ekubo’s strength and hope throughout his illness, noting that he planned to share his testimony with the world.
“Alexx bore his pain with remarkable strength, unwavering faith, and enduring hope, believing that one day his testimony would be shared with all,” the family wrote. They also requested privacy and prayers from fans and well-wishers during this difficult time. Further details regarding funeral arrangements will be shared at a later date.
Metastatic kidney cancer, also referred to as stage 4 renal cell carcinoma (RCC), is the most advanced stage of kidney cancer. According to the American Cancer Society, men are significantly more likely to develop kidney cancer than women, often due in part to factors such as smoking and workplace exposure to carcinogens.
The World Cancer Research Fund reported that kidney cancer ranks as the 14th most common cancer globally. In 2022, there were approximately 434,840 new cases and 155,953 deaths attributed to the disease.
Understanding Metastatic Kidney Cancer: Key Facts
-
Definition and Spread
Metastatic kidney cancer indicates that the cancer has spread beyond the kidney, affecting distant organs such as the lungs, bones, and liver. This stage presents significant treatment challenges compared to earlier stages. -
Late Symptoms
Early-stage kidney cancer often shows no symptoms. By the time it progresses to a metastatic stage, signs may include hematuria (blood in urine), persistent pain, unexplained weight loss, fatigue, and lack of appetite. -
Risk Factors
Major risk factors include smoking, obesity, high blood pressure, and family history of kidney cancer. The disease commonly affects individuals around the age of 60–65, but younger adults can also be diagnosed. -
Diagnosis at Advanced Stages
Studies show about one-third of RCC cases are diagnosed at a metastatic stage, contributing to more challenging prognoses. -
Survival Rates
The five-year relative survival rate for metastatic kidney cancer is approximately 15–19%. Previous median survival rates, without advanced treatments, were generally between 6 to 12 months. -
Advances in Treatment
Treatment options have improved considerably and may include targeted therapies, immunotherapy, surgery, and palliative care. Combination therapies have recently yielded better outcomes. -
Importance of Early Detection
Early detection increases the five-year survival rate to over 90% when the cancer is confined to the kidney, highlighting the need for immediate medical consultation for related symptoms. -
Unpredictable Progression
The progression of the disease can vary widely. Some patients may face rapid decline, while others respond favorably to treatment. -
Preventive Measures
Maintaining a healthy weight, avoiding smoking, managing blood pressure, and addressing warning signs can help reduce risk. -
Sickle Cell Trait and Disease
Inherited gene changes linked to sickle cell trait and disease have been associated with an increased risk of renal medullary carcinoma, a rare and aggressive form of kidney cancer.
As the public remembers Alexx Ekubo, awareness of kidney cancer and its implications becomes increasingly vital. Further research and advancements in treatment options remain essential in the fight against this disease.
